July 6, 2015
Alan R. Saltiel, PhD, whose studies of the hormone insulin have helped drive research of obesity, diabetes and other metabolic disorders across the nation, is joining University of California, San Diego School of Medicine as professor and director of a new Comprehensive Diabetes Center.
April 8, 2016
In a new study, published in the online edition of the journal EBioMedicine, a multi-disciplinary team led by researchers at University of California, San Diego School of Medicine has identified key inflammatory mechanisms underlying type 1 diabetes and obesity-related kidney dysfunction.
November 15, 2016
A new bioinformatic framework developed by researchers at University of California San Diego School of Medicine has identified key proteins significantly altered at the gene-expression level in biopsied tissue from patients with diabetic kidney disease, a result that may reveal new therapeutic targets.
December 18, 2012
UC San Diego Health System is collaborating with Qualcomm Life, a wholly owned subsidiary of Qualcomm Technologies, Inc. to pilot the 2net Platform and Hub for remote patient monitoring. Qualcomm Life’s innovative 2net™ technology collects patients’ clinical information from wireless medical devices and transmits it to UC San Diego Health…
August 23, 2023
With funding from The Leona M. and Harry B. Helmsley Charitable Trust, Jeremy Pettus, MD, an associate professor of medicine and board-certified endocrinologist who specializes in treating diabetes at UC San Diego Health, is leading a study on Liver Targeted Insulin (LTI) in Type 1 diabetes.
July 20, 2015
Once again, UC San Diego Health and its hospitals are ranked #1 in San Diego, and recognized among the best in the nation, by U.S. News & World Report for 2015-16. The annual U.S. News “Best Hospitals” rankings distinguish hospitals that excel in treating the most challenging health conditions.
July 15, 2024
Region’s only academic health system ranks No. 1 in San Diego and California with 11 medical and surgical specialties rated among nation’s best.
September 9, 2014
Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.
January 14, 2016
Pharmacists Helping to Redefine Diabetes Care Candis Morello leads the Diabetes Intensive Medical Management “tune up” clinic for patients at the Veterans Affairs San Diego Healthcare System. Photo by Ryan Parks Health care providers are facing increasing pressure to achieve better patient outcomes, faster. With that in mind, Candis Morello,…
December 17, 2020
Researchers report that hearing loss and high blood sugar are associated with poor cognitive performance among middle-aged and older Latinos.
